Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Phase I data on the pharmacokinetics and safety of CR-002

Nov. 14, 2005

KRP-103: A new NK1 antagonist for urinary incontinence

Nov. 10, 2005

Not approvable letter for premature ejaculation drug dapoxetine

Nov. 9, 2005

Novel therapeutics for genitourinary disorders claimed in recent Roche patent

Nov. 3, 2005

DPI-221 shows potential as an agent for overactive bladder and urinary incontinence

Nov. 2, 2005

Kyorin executes license with LG Life Sciences for KRP-197

Oct. 31, 2005

Phase II data on tadalafil in the treatment of BPH

Oct. 17, 2005

Rho kinase inhibitor improves responses of the cavernosal smooth muscle in rats

Oct. 14, 2005

Chugai patent describes new vitamin D receptor agonists for urological disorders

Oct. 14, 2005

Urigen receives IND clearance for phase IIb study of U-101

Oct. 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...